InsiderClue
Insiders · Profile

Campoy Carlos

Chief Financial Officer at CytomX Therapeutics. Filing since 20 Jul 2022. CIK 0001761518

Company
Date
Role
Action
Shares
Amount
Of holding
CTMX CytomX Therapeutics, Inc.
16 Mar 2023
Chief Financial Officer
Sold at will
1,748
$3.46K
4.4%
CTMX CytomX Therapeutics, Inc.
20 Jul 2022
Chief Financial Officer
Sold, plan not stated
3,949
$5.62K
9.0%
2 decisions on file.